Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Immune checkpoint LAG3 marks a subset of exhausted Natural Killer Cells

FY 2022-23

Summary
Cancer occurs when our cells develop harmful changes to their DNA and begin to take over our healthy cells making us sick. Fortunately, our healthy cells have their own bodyguards, called Natural Killer (NK) cells. NK cells are immune cells that are able to destroy cancer cells using special weapons. These special weapons can activate and recruit other immune cells which causes the cancer cell to die. However, in cancer, the NK cells become overworked by the large number of harmful cells and run out of these special weapons. This is called NK cell exhaustion, and it leads to the cancer growing. Exhausted NK cells share a common uniform, a display of structures on their cell surface referred to as immune checkpoints. One type of immune checkpoint is called LAG3. When T cells, another type of immune cell, express LAG3, they become poor at killing harmful cells and grow less. However, no one knows what role LAG3 plays in NK cells. We show that LAG3 causes NK cells to produce fewer special weapons suggesting these NK cells would be poor at killing tumor cells. To understand what the mechanism is behind this, a molecular analysis was performed to understand what genes are increased in NK cells with LAG3. We found that LAG3-expressing NK cells have increased genes associated with proliferation and metabolic activity, the opposite to what was seen in T cells. To determine if LAG3 causes NK cells to have decreased killing capacities and increased proliferation, we will perform experiments using a mouse model where LAG3 was deleted from NK cells. When corroborated, our research will show LAG3 serves as a switch between a NK cell population that has increased proliferation when LAG3 is present or that has increased killing capacities of cancer cells when LAG3 is absent.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486040
Name
Vasilyeva Valeria E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Immune checkpoint LAG3 marks a subset of exhausted Natural Killer Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Proliferation; Chronic Viral Disease; Immune Checkpoints; Immuno-Oncology; Immunology; Immunotherapies; Innate Immunity; Lag3; Natural Killer Cells; Tumor Microenvironment
Abstract
Cancer occurs when our cells develop harmful changes to their DNA and begin to take over our healthy cells making us sick. Fortunately, our healthy cells have their own bodyguards, called Natural Killer (NK) cells. NK cells are immune cells that are able to destroy cancer cells using special weapons. These special weapons can activate and recruit other immune cells which causes the cancer cell to die. However, in cancer, the NK cells become overworked by the large number of harmful cells and run out of these special weapons. This is called NK cell exhaustion, and it leads to the cancer growing. Exhausted NK cells share a common uniform, a display of structures on their cell surface referred to as immune checkpoints. One type of immune checkpoint is called LAG3. When T cells, another type of immune cell, express LAG3, they become poor at killing harmful cells and grow less. However, no one knows what role LAG3 plays in NK cells. We show that LAG3 causes NK cells to produce fewer special weapons suggesting these NK cells would be poor at killing tumor cells. To understand what the mechanism is behind this, a molecular analysis was performed to understand what genes are increased in NK cells with LAG3. We found that LAG3-expressing NK cells have increased genes associated with proliferation and metabolic activity, the opposite to what was seen in T cells. To determine if LAG3 causes NK cells to have decreased killing capacities and increased proliferation, we will perform experiments using a mouse model where LAG3 was deleted from NK cells. When corroborated, our research will show LAG3 serves as a switch between a NK cell population that has increased proliferation when LAG3 is present or that has increased killing capacities of cancer cells when LAG3 is absent.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vasilyeva, Valeria E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~